Why Generic Drug Makers May Benefit from 505(b)(2) Approval
This article was originally published at https://www.drugpatentwatch.com/blog/why-generic-drug-makers-may-benefit-from-505b2-approval/
A few years ago, there was much talk of the “patent cliff” facing blockbuster drugs like Lipitor and other huge name-brand drugs. The “patent cliff” may have spelled the end… The post Why Generic Drug Makers May Benefit from 505(b)(2) Approval appeared first on DrugPatentWatch - Make Better Decisions.Comments are closed.